Richard Rosenquist Brandell is Professor of Clinical Genetics at Karolinska Institutet, and Senior Physician at Karolinska University Hospital. He is Director of Genomic Medicine Sweden, a national infrastructure for implementation of precision medicine. Focusing on hematological malignancies and utilizing high-throughput sequencing technologies, his team has identified novel prognostic and predictive biomarkers that have significantly improved patient risk-stratification and clinical decision-making. Rosenquist Brandell is a member of the Nobel Assembly at Karolinska Institutet.
Richard Rosenquist Brandell
Professor of Clinical Genetics at Karolinska Institutet, and Senior Physician at Karolinska University Hospital.
